- CA$16.17m
- CA$22.65m
- CA$0.46m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 41.6 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -983.43% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 0.86 | 0.53 | 0.56 | 0.51 | 0.46 | n/a | n/a | -15.95% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.
Directors
- Robert von der Porten CHM
- Lesley Bourget CFO
- Michael Druhan CEX
- Louie Canitano COO
- Paul Karam DSL
- Wayne Cockburn IND
- David Hennigar IND
- Kenneth McKay IND
- Anthony Milonas IND
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- April 15th, 1999
- Public Since
- February 12th, 2008
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
TSX Venture Exchange- Shares in Issue
- 269,456,602
- Address
- 1495 Bonhill Road, Unit # 1 Mississauga, MISSISSAUGA, L5T 1M2
- Web
- https://medxhealth.com/
- Phone
- +1 9056704428
- Auditors
- Kreston GTA LLP
Upcoming Events for MDX
Q3 2024 Medx Health Corp Earnings Release
Similar to MDX
Aurora Spine
TSX Venture Exchange
CardioComm Solutions
TSX Venture Exchange
Enablence Technologies
TSX Venture Exchange
EvokAI Creative Labs
TSX Venture Exchange
Evome Medical Technologies
TSX Venture Exchange
FAQ
What is the Medx Health share price?
As of Today at 22:00 UTC, shares in Medx Health are trading at CA$0.06. This share price information is delayed by 15 minutes.
How has the Medx Health share price performed this year?
Shares in Medx Health last closed at CA$0.06 and the price had moved by -7.69% over the past 365 days. In terms of relative price strength the Medx Health share price has underperformed the Toronto Stock Exchange 300 Composite Index by -24.71% over the past year.
What are the analyst and broker recommendations for Medx Health?
The overall consensus recommendation for Medx Health is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Medx Health dividend yield?
Medx Health does not currently pay a dividend.
Does Medx Health pay a dividend?
Medx Health does not currently pay a dividend.
When does Medx Health next pay dividends?
Medx Health does not currently pay a dividend.
How do I buy Medx Health shares?
To buy shares in Medx Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Medx Health?
As of the previous close price of CA$0.06, shares in Medx Health had a market capitalisation of CA$16.17m.
Where are Medx Health shares listed?
Here are the trading details for Medx Health:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: MDX
What kind of share is Medx Health?
Based on an overall assessment of its quality, value and momentum Medx Health is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Medx Health share price forecast for 2024?
The analyst consensus target price for shares in Medx Health is CA$0.45. That is 650% above the last closing price of CA$0.06.
Analysts covering Medx Health currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the Medx Health share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medx Health. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -20.62%.
As of the last closing price of CA$0.06, shares in Medx Health were trading -4.38% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Medx Health PE Ratio?
The Medx Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.06.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Medx Health?
Medx Health's management team is headed by:
- Robert von der Porten - CHM
- Lesley Bourget - CFO
- Michael Druhan - CEX
- Louie Canitano - COO
- Paul Karam - DSL
- Wayne Cockburn - IND
- David Hennigar - IND
- Kenneth McKay - IND
- Anthony Milonas - IND